Search research articles
Contact Us
Filters
Showing results (1-10 of 157) with videos related to
Page
of 16
Sort By:
Current Drug Targets
|
August 17, 2018
Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders
Rakesh Kumar Singh, Abul Kalam Najmi
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 18, 2016
Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective
Tushar Madaan, Mohd Akhtar, Abul Kalam Najmi
Journal of Evidence-Based Medicine
|
November 27, 2019
Anemia prevalence and its impact on health-related quality of life in Indian diabetic kidney disease patients: Evidence from a cross-sectional study
Salman Hussain, Anwar Habib, Abul Kalam Najmi
Assay and Drug Development Technologies
|
March 10, 2026
Neprilysin Inhibitor and Angiotensin Receptor Blocker Attenuate Ischemic Brain Injury: Unveiling the Kinin-Mediated Pathway
Geetika Mehta, Monika Sachdeva, Abul Kalam Najmi
Drug Research
|
October 9, 2018
A Natural Phenolic Compound Quercetin Showed the Usefulness by Targeting Inflammatory, Oxidative Stress Markers and Augment 5-HT Levels in One of the Animal Models of Depression in Mice
Khadeeja Khan, Abul Kalam Najmi, Mohd Akhtar
International Journal of Environmental Research and Public Health
|
April 26, 2019
Limited Knowledge of Chronic Kidney Disease among Type 2 Diabetes Mellitus Patients in India
Salman Hussain, Anwar Habib, Abul Kalam Najmi
Journal of Evidence-Based Medicine
|
December 2, 2017
Role of Cochrane Reviews in informing US private payers' policies
Ambrish Singh, Salman Hussain, Abul Kalam Najmi
Urology Journal
|
October 1, 2013
Mirabegron for overactive bladder: a novel, first-in-class β3-agonist therapy
Mohammed Imran, Abul Kalam Najmi, Shams Tabrez
Journal of Molecular Histology
|
November 27, 2024
Levocabastine ameliorates cyclophosphamide-induced hepatotoxicity in Swiss albino mice: modulation of Nrf2, NF-κB p65, cleaved caspase-3 and TGF-β signaling molecules
Wasim Akram, Abul Kalam Najmi, Syed Ehtaishamul Haque
Fundamental & Clinical Pharmacology
|
October 15, 2013
Protective effect of a direct renin inhibitor in acute murine model of cardiotoxicity and nephrotoxicity
Azhar Rashikh, Krishna Kolappa Pillai, Abul Kalam Najmi
Page
of 16
Search research articles
Search
Showing results (1-10 of 157) with videos related to
Sort By:
Page
of 16
Current Drug Targets
|
August 17, 2018
Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders
Rakesh Kumar Singh, Abul Kalam Najmi
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 18, 2016
Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective
Tushar Madaan, Mohd Akhtar, Abul Kalam Najmi
Journal of Evidence-Based Medicine
|
November 27, 2019
Anemia prevalence and its impact on health-related quality of life in Indian diabetic kidney disease patients: Evidence from a cross-sectional study
Salman Hussain, Anwar Habib, Abul Kalam Najmi
Assay and Drug Development Technologies
|
March 10, 2026
Neprilysin Inhibitor and Angiotensin Receptor Blocker Attenuate Ischemic Brain Injury: Unveiling the Kinin-Mediated Pathway
Geetika Mehta, Monika Sachdeva, Abul Kalam Najmi
Drug Research
|
October 9, 2018
A Natural Phenolic Compound Quercetin Showed the Usefulness by Targeting Inflammatory, Oxidative Stress Markers and Augment 5-HT Levels in One of the Animal Models of Depression in Mice
Khadeeja Khan, Abul Kalam Najmi, Mohd Akhtar
International Journal of Environmental Research and Public Health
|
April 26, 2019
Limited Knowledge of Chronic Kidney Disease among Type 2 Diabetes Mellitus Patients in India
Salman Hussain, Anwar Habib, Abul Kalam Najmi
Journal of Evidence-Based Medicine
|
December 2, 2017
Role of Cochrane Reviews in informing US private payers' policies
Ambrish Singh, Salman Hussain, Abul Kalam Najmi
Urology Journal
|
October 1, 2013
Mirabegron for overactive bladder: a novel, first-in-class β3-agonist therapy
Mohammed Imran, Abul Kalam Najmi, Shams Tabrez
Journal of Molecular Histology
|
November 27, 2024
Levocabastine ameliorates cyclophosphamide-induced hepatotoxicity in Swiss albino mice: modulation of Nrf2, NF-κB p65, cleaved caspase-3 and TGF-β signaling molecules
Wasim Akram, Abul Kalam Najmi, Syed Ehtaishamul Haque
Fundamental & Clinical Pharmacology
|
October 15, 2013
Protective effect of a direct renin inhibitor in acute murine model of cardiotoxicity and nephrotoxicity
Azhar Rashikh, Krishna Kolappa Pillai, Abul Kalam Najmi
Page
of 16